Disclaimer
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Future Medicine Ltd.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.
Additional information
Notes on contributors
Renu Virmani
Renu Virmani speaks to Ellen Clarke, Commissioning Editor:R Virmani is a world-renowned cardiovascular pathologist and is recognized as a leading researcher in the field of cardiovascular disease treatments. Presented with the 2012 TCT Career Achievement Award by the Cardiovascular Research Foundation, as well as honorary awards by ESC and EuroPCR for her dedicated research work, she proctors across the globe delivering more than 800 presentations at scientific meetings and has authored or coauthored over 600 publications in peer-reviewed journals and is also a manuscript reviewer for many major scientific journals.